1. Ascend recalls dabigatran etexilate capsules due to nitrosamine impurity

   News item 08 April 2023 Pages: 1 - 1

2. JAK inhibitor safety information updated with risk minimisation measures

   News item 08 April 2023 Pages: 2 - 2

3. JAK inhibitors increase risk of MI, thrombosis, cancer and serious infections

   News item 08 April 2023 Pages: 3 - 3

4. One lot of atovaquone recalled due to potential contamination

   News item 08 April 2023 Pages: 4 - 4

5. Paxlovid and tacrolimus drug interaction

   News item 08 April 2023 Pages: 5 - 5

6. Core data elements for pregnancy pharmacovigilance studies

   Clinical study 08 April 2023 Pages: 6 - 6

7. COVID-19 vaccination safety during pregnancy

   Clinical study 08 April 2023 Pages: 7 - 7

8. Design criteria impact reference sets for signal detection algorithms for drug interactions

   Clinical study 08 April 2023 Pages: 8 - 8

9. Drug hypersensitivity reactions increase risk of anxiety and depression

   Clinical study 08 April 2023 Pages: 9 - 9

10. Experiences after first COVID-19 vaccination impact severity of AEs after second dose

    Clinical study 08 April 2023 Pages: 10 - 10

11. Fluoroquinolone: no impact of regulatory interventions to reduce use in the EU/UK

    Clinical study 08 April 2023 Pages: 11 - 11

12. GLP-1 receptor agonist-related risk of pancreatic cancer

    Clinical study 08 April 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 08 April 2023 Pages: 13 - 13

14. Abemaciclib/palbociclib

    Case report 08 April 2023 Pages: 14 - 14

15. Acalabrutinib

    Case report 08 April 2023 Pages: 15 - 15

16. Aciclovir

    Case report 08 April 2023 Pages: 16 - 16

17. Acitretin

    Case report 08 April 2023 Pages: 17 - 17

18. Acitretin/apremilast

    Case report 08 April 2023 Pages: 18 - 18

19. Acitretin/methotrexate/tozinameran

    Case report 08 April 2023 Pages: 19 - 19

20. Adapalene/unspecified steroids

    Case report 08 April 2023 Pages: 20 - 20

21. Adenosine-triphosphate/amiodarone

    Case report 08 April 2023 Pages: 21 - 21

22. Alcohol/difenidol

    Case report 08 April 2023 Pages: 22 - 22

23. Alendronic-acid

    Case report 08 April 2023 Pages: 23 - 23

24. Amikacin/imipenem/norepinephrine

    Case report 08 April 2023 Pages: 24 - 24

25. Amikacin/meropenem

    Case report 08 April 2023 Pages: 25 - 25

26. Amiodarone

    Case report 08 April 2023 Pages: 26 - 26

27. Amiodarone/beta-adrenergic-receptor-antagonists/digoxin

    Case report 08 April 2023 Pages: 27 - 27

28. Amiodarone/lidocaine

    Case report 08 April 2023 Pages: 28 - 28

29. Amlodipine/propranolol

    Case report 08 April 2023 Pages: 29 - 29

30. Amoxicillin/clavulanic-acid

    Case report 08 April 2023 Pages: 30 - 30

31. Amoxicillin/clavulanic-acid/moxifloxacin

    Case report 08 April 2023 Pages: 31 - 31

32. Anakinra/antiepileptic-drugs

    Case report 08 April 2023 Pages: 32 - 32

33. Antiarrhythmics/ondansetron

    Case report 08 April 2023 Pages: 33 - 33

34. Antibacterials

    Case report 08 April 2023 Pages: 34 - 34

35. Antibacterials

    Case report 08 April 2023 Pages: 35 - 35

36. Antibacterials/antifungal/steroids

    Case report 08 April 2023 Pages: 36 - 36

37. Antibacterials/BCG

    Case report 08 April 2023 Pages: 37 - 37

38. Antibacterials/corticosteroids

    Case report 08 April 2023 Pages: 38 - 38

39. Antibacterials/dopamine

    Case report 08 April 2023 Pages: 39 - 39

40. Antibacterials/immunosuppressants/lisinopril

    Case report 08 April 2023 Pages: 40 - 40

41. Antibacterials/proton pump inhibitors

    Case report 08 April 2023 Pages: 41 - 41

42. Antiepileptic-drugs

    Case report 08 April 2023 Pages: 42 - 42

43. Antifungals/Glucocorticoids

    Case report 08 April 2023 Pages: 43 - 43

44. Antihyperglycaemics/dexamethasone

    Case report 08 April 2023 Pages: 44 - 44

45. Antihypertensives

    Case report 08 April 2023 Pages: 45 - 45

46. Antineoplastics

    Case report 08 April 2023 Pages: 46 - 46

47. Antineoplastics

    Case report 08 April 2023 Pages: 47 - 47

48. Antineoplastics

    Case report 08 April 2023 Pages: 48 - 48

49. Antineoplastics

    Case report 08 April 2023 Pages: 49 - 49

50. Antineoplastics

    Case report 08 April 2023 Pages: 50 - 50